Mutations in specific codons of the KRAS oncogene are associated with variable resistance to neoadjuvant chemoradiation therapy in patients with rectal adenocarcinoma - Duldulao, M P; Lee, W; Nelson, R A (Ann Surg Oncol, 2013)
, et al.